Share:

Percutaneous Coronary Intervention (PCI) Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Catheters, Coronary Guidewires, Embolic Protection Devices), By Applications (Hospitals, Ambulatory Surgical Centers, Catherization Labs), By End Use, By Region, and Segment Forecasts - 2035

Last Updated: 10 August 2026
Base Year: 2025
Historical Data: 2021-2024
No of Pages: 94
  • The Percutaneous Coronary Intervention (PCI) Devices Market is projected to reach USD 6097.29 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.

  • What is the expected CAGR of the Percutaneous Coronary Intervention (PCI) Devices Market during 2026-2035?

    The Percutaneous Coronary Intervention (PCI) Devices Market is expected to grow at a CAGR of 3.4% during the forecast period from 2026 to 2035.

  • Which companies are leading the Percutaneous Coronary Intervention (PCI) Devices Market?

    Key players in the Percutaneous Coronary Intervention (PCI) Devices Market market include Boston Scientific (USA), Abbott (USA), Medtronic (USA), Cordis (USA), Terumo Medical (Japan), AMG International (Germany), ASAHI INTECC (Japan), B. Braun Melungeon (Germany), Biosensors (Singapore), BIOTRONIK(Germany), BrosMed Medical (China), Claret Medical (USA)

  • How large was the Percutaneous Coronary Intervention (PCI) Devices Market in 2025?

    The Percutaneous Coronary Intervention (PCI) Devices Market was valued at USD 5334.03 Million in 2025, reflecting strong demand and continued adoption across major industries.

What is included in this Sample?

man icon
Mail icon
Captcha refresh